Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease

Lancet

Volumn 358, Issue 9291, 2001, Pages 1389-1399

  Beral, Valerie ^b   Bull, Diana ^b   Doll, Richard ^b   Peto, Richard ^b   Reeves, Gillian ^b   Skegg, David ^b   Colditz, Graham ^b   Hulka, Barbara ^b   La Vecchia, Carlo ^b   Magnusson, Cecelia ^b   Miller, Tony ^b   Peterson, Bert ^b   Pike, Malcolm ^b   Rookus, Matti ^b   Thomas, David ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PARITY; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL MODEL;

EID: 0035960431     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)06524-2     Document Type: Article

References (55)

1. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies
2. Breast cancer and hormonal contraceptives: Further results
3. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
4. Oral contraceptives and breast cancer: Final report of an epidemiologic study
5. Oral contraceptive use and breast cancer or cervical cancer: Preliminary results of a French case-control study
6. Childhood and recent eating patterns and risk of breast cancer
7. Oral contraceptive use and breast cancer in young women: A joint national case-control study in Sweden and Norway
8. The association of replacement estrogens with breast cancer
9. Role of fat, animal protein and dietary fibre in breast cancer aetiology: A case-control study
10. Risk factors for breast cancer with applications to selection for the prevelance screen
11. A case-control study of breast cancer and hormonal contraception in Costa Rica
12. A case-control study of breast cancer in relation to oral contraceptive use in Slovenia
13. Oral contraceptive agents and breast cancer: A population-based case-control study
14. Risk factors for breast cancer in Chinese women in Shanghai
15. Prospective study of oral contraceptive use and the risk of breast cancer in women
16. Breast cancer and breast feeding: Results from an Australian case-control study
17. Oral contraceptives and breast cancer: Results from an expanded case-control study
18. Oral contraceptive use and breast cancer risk in young women
19. Early oral contraceptive use and breast cancer: Results of another case-control study
20. Oral contraceptives and risk of breast cancer
21. Oral contraceptives and breast cancer: A case-control study with hospital and community controls
22. Oral contraceptives and breast cancer: A French case-control study
23. Risk factors for female breast cancer: A hospital based case-control study in Madras, India
24. The pattern of risk factors for breast cancer in a Southern France population: Interest for a stratified analysis by age at diagnosis
25. Breast cancer risk and oral contraceptive use: Results from a large case-control study
26. Age-specific differences in the relationship between oral contraceptive use and breast cancer
27. Risk factors for breast cancer by age and menopausal status: A case-control study in Singapore
28. Canadian National Breast Screening Study, I: Breast cancer detection and death rates among women aged 40-49 years
29. A case-control study of the risk of breast cancer in relation to oral contraceptive use
30. Effect of family history, body fat distribution, and reproductive factors on risk of postmenopausal breast cancer
31. A case-control study of breast cancer in Tianjin, China
32. Non contraceptive hormone use and risk of breast cancer
33. Family history, age, and risk of fatal breast cancer
34. Age at last full-term pregnancy and risk of breast cancer
35. Oral contraceptives and breast cancer in Northern Italy: Final report from a case-control study
36. Lactation and a reduced risk of premenopausal breast cancer
37. Risk factors for breast cancer among Filipino women
38. Oral contraceptives and risk of breast cancer in women aged 20-54 years
39. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States)
40. Breast cancer among young US women in relation to oral contraceptive use
41. Oral contraceptives and breast cancer risk among younger women
42. Oral contraceptives and breast cancer: A cooperative Italian study
43. Oral contraceptives, menopausal estrogens, and the risk of breast cancer: A case-control study in Greece
44. Breast cancer risk and oral contraceptive use in Slovenian women aged 25 to 54
45. Exogenous hormones and the risk of postmenopausal breast cancer: Results from the Netherlands cohort study
46. Alcohol and breast cancer in the Swiss Canton of Vaud
47. Oral contraceptive use and risk of breast cancer in middle-aged women
48. A breast case-control study in Girona, Spain. Endocrine, familial and lifestyle factors
49. Breast cancer in Australian women under the age 40
50. Comparative case-referent study of risk factors among hormone-related female cancers in Japan
51. Design and analysis issues in a population-based case-control-family study of the genetic epidemiology of breast cancer, and the Cooperative Family Registry for Breast Cancer Families (CFRBCS)
52. Breast cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy
53. The Million Women Study: Design and characteristics of the study population
54. Floating absolute risk: An alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group